Managing the alliance relationship with an industrial partner competitor poses a major challenge to companies. The alliance generates, Indeed, opportunities and risks that may be associated with opportunistic behavior. It is a covenant relationship around a drug that is considered innovative in this article. The study demonstrates the relevance of the combination approach of real options with game theory to determine the optimal timing of the entry of a competitor industrial partner in an innovative project.